Keywords: texas, biotech, announces, initiation, ph, ii, argatroban

Texas Biotech announces initiation of Ph II argatroban trial

Article | 11 October 2001

l Texas Biotechnology says that marketing partner GlaxoSmithKline hasinitiated a Phase II clinical trial to evaluate the safety and efficacy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in